Skip to main content
News, talk and articles

The latest news from PTC

  1. Para.Ghost Logo

    Martin Stengård: Making Esports Champions with DuchenneCan mindset

    Martin Stengård has many strings to his bow. Following his pursuit of music as a student and retraining in the software development industry, he is now working as a full-time cyber security specialist. Above all this, however, he is the proud father of Sigge, his 15-year-old son who is living with Duchenne muscular dystrophy. For…
    Rare Disease Community
    February 2, 2023
    4 minutes
    READ MORE
  2. Lila banner

    Lila Plakolli: Empowering others to embrace who they are

    Lila is a disability activist and performer living with Duchenne. Through their dynamic theatre performances and powerful advocacy speeches encouraging self-pride and self-expression, Lila is empowering others to accept and embrace who they are. Lila’s childhood began in Kosovo, but they moved to Switzerland as a child, where they were diagnosed with Duchenne muscular dystrophy…
    Rare Disease Community
    December 20, 2022
    2 minutes
    READ MORE
  3. 2022: A Year of Many Firsts

    For PTC, 2022 was a milestone-reaching, patient-supporting, award-winning, employee-engaging, community-driven year. It was also another year of many firsts. The first approved disease-modifying treatment for AADC deficiency, and the first marketed gene therapy directly infused into the brain, was approved in Europe and the UK. We also had the first global regulatory approval for treatment…
    Science & Innovation
    December 15, 2022
    4 minutes
    READ MORE
  4. Award

    BioTech Breakthrough Awards: PTC is 2022 BioTechnology Innovator of the Year

    PTC has been selected as “BioTechnology Innovator of the Year” in the second annual BioTech Breakthrough Awards program conducted by BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology companies, products and services around the globe. The award comes in recognition of our use of pioneering science…
    Science & Innovation
    November 28, 2022
    1 minutes
    READ MORE
  5. Podcast

    Take on Duchenne Podcast: Women & Duchenne

    We are dedicating this episode to ‘Women & Duchenne’ in honor of World Duchenne Awareness Day which takes place every September 7. Tune in to hear from three incredible women: a clinical expert, a mother who is also a carrier and caregiver, and a scientist share their knowledge, perspectives and experiences. Each has a set…
    Rare Disease Community
    November 21, 2022
    3 minutes
    READ MORE
  6. National Family Caregivers Month: Thank You, Caregivers

    National Family Caregivers Month (NFCM), which takes place each November, is a time to recognize and express gratitude for the more than 50 million Americans who provide care and medical assistance to their loved ones, including parents, children and siblings. We’d like to take this time to thank caregivers in the U.S. for their selfless…
    Rare Disease Community
    November 17, 2022
    2 minutes
    READ MORE
  7. Ireland Award

    PTC is a Finalist in Two Pharma Industry Awards in Ireland

    PTC was thrilled to be shortlisted as a finalist in the Pharma Industry Awards in two categories, Biotech Company of the Year and Supply Chain Achievement Award, alongside remarkable companies and organizations in Ireland’s pharma industry. The Pharma Industry Awards recognize and celebrate the most original and innovative individuals and companies that demonstrate excellence in…
    Business & Finance, Rare Disease Community, Science & Innovation
    November 15, 2022
    2 minutes
    READ MORE
  8. Brain

    An innovative supply chain model for an innovative product

    In July 2022, PTC’s first gene therapy and disease-modifying treatment for Aromatic l‐amino acid decarboxylase (AADC) deficiency was approved by the European Commission (EC). In this relatively new field of molecular medicine, PTC is one of the pioneers in the gene therapy, being the first therapy to be injected directly into the brain. Unlike the…
    Rare Disease Community, Science & Innovation
    November 15, 2022
    4 minutes
    READ MORE
  9. Planting Trees

    PTC Planting Trees for the Future

    Last week in Switzerland, PTC colleagues teamed up to plant trees in an effort to make an environmental impact. In partnership with OneTree Planted and Almighty Tree this year, 100 Oak trees were planted to help combat climate change and prevent biodiversity loss for generations to come. Tree planting is critical to reforestation and afforestation…
    Our Culture, Responsibility
    November 7, 2022
    1 minutes
    READ MORE
  10. Europe

    Preparing Europe for a new generation of innovative therapies

    Thomas Bols, Head of Government Affairs and Patient Advocacy, EMEA and APAC at PTC, recently shared his perspective with Open Access Government on how preparing Europe for a new generation of innovative therapies has the potential to transform the lives of patients. Gene therapies are bringing hope to patients living with ultra-rare diseases. In the…
    Rare Disease Community, Science & Innovation
    November 3, 2022
    2 minutes
    READ MORE